Home / Brands / Wells Pharma of Houston
Wells Pharma of Houston Recalls
8 recalls on record · December 13, 2023 to May 6, 2026 · Drugs
Recalls by year
23
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15
Hazard: cGMP deviations.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054,
Hazard: cGMP deviations.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC
Hazard: cGMP deviations.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC
Hazard: cGMP deviations.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag,
Hazard: cGMP deviations.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Housto
Hazard: cGMP deviations.
May 6, 2026DrugsFDA
Wells Pharma of Houston LLC recalls Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03
Hazard: cGMP deviations.
December 13, 2023DrugsFDA
Wells Pharma of Houston LLC recalls ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Ph
Hazard: Lack of assurance of sterility.